Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage

Hua Lu1, Ji-Xin Shi, Hui-Lin Chen

  • 1Department of Neurosurgery, Jinling Hospital, Clinical School of Nanjing University, 305 East Zhongshan Road, Nanjing 210002, China.

Brain Research
|April 30, 2009
PubMed

Insights

Monocyte chemoattractant protein-1 (MCP-1) levels increase with cerebral vasospasm after subarachnoid hemorrhage (SAH) in rats. Targeting MCP-1 may help prevent or reduce vasospasm following SAH.

Area of Science:

  • Neuroscience
  • Immunology
  • Vascular Biology

Background:

  • Monocyte chemoattractant protein-1 (MCP-1) is a key chemokine in macrophage recruitment.
  • MCP-1 is implicated in central nervous system inflammation but its role in cerebral vasospasm post-subarachnoid hemorrhage (SAH) is understudied.

Purpose of the Study:

  • To investigate MCP-1 expression in a rat model of SAH.
  • To clarify the potential role of MCP-1 in the development of cerebral vasospasm.

Main Methods:

  • An experimental SAH model was created in 80 rats, divided into control and SAH groups (days 3, 5, 7).
  • Basilar artery cross-sectional area was measured.
  • MCP-1 expression was assessed using real-time PCR, Western blot, and immunohistochemistry.

Main Results:

  • Subarachnoid hemorrhage induced significant basilar artery vasospasm, peaking on day 5.
  • Elevated MCP-1 mRNA and protein levels were detected post-SAH, mirroring the vasospasm timeline.
  • MCP-1 expression correlated with the severity of cerebral vasospasm.

Conclusions:

  • MCP-1 expression parallels the development of cerebral vasospasm after experimental SAH in rats.
  • These findings suggest MCP-1 antagonists could be a therapeutic strategy for mitigating SAH-induced vasospasm.